Glyceryl Monostearate: Probing the Self Assembly of a Lipid Amenable To Surface Modification for Hepatic Targeting
Source abstract
Abstract
Glyceryl monostearate (GMS) is a single-tailed lipidic monoglyceride commonly used as a nontoxic food additive. In this study, we have investigated GMS, specifically its self-assembling properties and subsequent application in drug delivery. Results from in silico modeling, corroborated by complementary small-angle neutron scattering, demonstrated vesicle formation; associated phase transitions were analyzed using differential scanning calorimetry; dynamic light scattering revealed particle size alterations that occurred in the transition region. Spherical morphology of unilamellar vesicles was visualized using transmission electron microscopy imaging. Further, hydrophilic and hydrophobic drug loading in GMS vesicles and their amenability to surface modification for hepatic targeting have, in this study, been both predicted through molecular simulation study and demonstrated experimentally. The influence of hepatotropic ligands on the stability of drug-loaded GMS vesicles vis-à-vis cholesterol has also been investigated; the resulting GMS-based drug delivery vehicle, its properties enhanced through surface decoration, is envisaged to achieve targeted delivery of its payload to hepatocytes.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Lipid Membrane Structure and Behavior · Surfactants and Colloidal Systems · RNA Interference and Gene Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Pharmaceutics, Bombay College of Pharmacy, Kalina, Santacruz (East), Mumbai 400098, India
Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Helsinki FI-00014, Finland
Solid State Physics Division, Bhabha Atomic Research Centre, Trombay, Mumbai 400085, India
Funding
Council of Scientific and Industrial Research · Magnus Ehrnroothin S??ti? · Suomen Akatemia · Suomen Kulttuurirahasto · Amrut Mody Research Fund
References (64)
Show source-provided references
1. 10.1016/j.jconrel.2012.03.02010.1016/j.jconrel.2012.03.020 ↗
2. 10.1016/j.bbamem.2016.02.02510.1016/j.bbamem.2016.02.025 ↗
3. 10.1002/anie.19920709110.1002/anie.199207091 ↗
4. 10.1021/ja00522a01910.1021/ja00522a019 ↗
5. 10.1126/science.278128310.1126/science.2781283 ↗
6. 10.1016/j.jconrel.2017.09.04010.1016/j.jconrel.2017.09.040 ↗
7. 10.1016/0304-4157(95)00008-910.1016/0304-4157(95)00008-9 ↗
8. 10.1016/j.tifs.2005.12.01210.1016/j.tifs.2005.12.012 ↗
9. 10.13005/bpj/42510.13005/bpj/425 ↗
10. 10.1016/j.dit.2013.06.01110.1016/j.dit.2013.06.011 ↗
11. 10.1080/0265204080237990210.1080/02652040802379902 ↗
12. 10.9734/bjpr/2013/277010.9734/bjpr/2013/2770 ↗
13. 10.1016/j.dit.2013.03.00610.1016/j.dit.2013.03.006 ↗
14. 10.1166/jbn.2008.32010.1166/jbn.2008.320 ↗
15. 10.1080/0193269090312012810.1080/01932690903120128 ↗
16. 10.1021/mp100305h10.1021/mp100305h ↗
17. 10.1021/j100142a00410.1021/j100142a004 ↗
18. Frisch, M.; Trucks, G.; Schlegel, H. B.; Scuseria, G.; Robb, M.; Cheeseman, J.; Montgomery, J., Jr; Vreven, T.; Kudin, K.; Burant, J. Gaussian 03, Revision C 02; Gaussian, Inc.: Wallingford, CT 2004; p 26.
19. 10.1016/j.jmgm.2005.12.00510.1016/j.jmgm.2005.12.005 ↗
20. 10.1021/ct300342n10.1021/ct300342n ↗
21. 10.1021/jp212503e10.1021/jp212503e ↗
22. 10.1063/1.32869310.1063/1.328693 ↗
23. 10.1063/1.44733410.1063/1.447334 ↗
24. 10.1103/physreva.31.169510.1103/physreva.31.1695 ↗
25. 10.1063/1.44586910.1063/1.445869 ↗
26. 10.1002/(sici)1096-987x(199709)18:12<1463::aid-jcc4>3.3.co;2-l10.1002/(sici)1096-987x(199709)18:12<1463::aid-jcc4>3.3.co;2-l ↗
27. 10.1063/1.47011710.1063/1.470117 ↗
28. 10.1063/1.142136210.1063/1.1421362 ↗
29. 10.1093/bioinformatics/btt05510.1093/bioinformatics/btt055 ↗
30. 10.1016/0263-7855(96)00018-510.1016/0263-7855(96)00018-5 ↗
31. 10.1016/j.ejps.2012.02.00910.1016/j.ejps.2012.02.009 ↗
32. 10.1021/la00002a05710.1021/la00002a057 ↗
33. 10.1021/la001699p10.1021/la001699p ↗
34. 10.1021/j100665a01810.1021/j100665a018 ↗
35. Israelachvili J. N. · 2011 · 3 · 535
36. 10.1016/0021-9797(79)90331-x10.1016/0021-9797(79)90331-x ↗
37. 10.1529/biophysj.104.04887610.1529/biophysj.104.048876 ↗
38. Ghosh P. · 2009
39. 10.1016/0005-2736(91)90253-510.1016/0005-2736(91)90253-5 ↗
40. Il’Icheva T. · Vopr. Onkol. · 1998 · 44 · 390
41. Marwah, M. S. Novel Systems for Targeted Drug Delivery to Liver: Design, Formulation and Evaluation. Ph.D. Dissertation, University of Mumbai: India, 2018.
42. 10.1016/j.chemphyslip.2012.11.00210.1016/j.chemphyslip.2012.11.002 ↗
43. 10.1021/la062875i10.1021/la062875i ↗
44. 10.1021/jp025849b10.1021/jp025849b ↗
45. 10.1016/s0006-3495(99)77050-510.1016/s0006-3495(99)77050-5 ↗
46. 10.1111/j.1365-2818.2010.03484.x10.1111/j.1365-2818.2010.03484.x ↗
47. 10.1107/s002188989100369210.1107/s0021889891003692 ↗
48. Bevington P. R. · 1969
49. 10.1007/bf0270405210.1007/bf02704052 ↗
50. 10.1021/jp047510q10.1021/jp047510q ↗
51. 10.1016/j.bbamem.2005.10.01710.1016/j.bbamem.2005.10.017 ↗
52. 10.1016/j.bbamem.2006.11.00310.1016/j.bbamem.2006.11.003 ↗
53. 10.1529/biophysj.103.03668110.1529/biophysj.103.036681 ↗
54. 10.1103/physreve.59.336110.1103/physreve.59.3361 ↗
55. 10.1073/pnas.73.11.386210.1073/pnas.73.11.3862 ↗
56. 10.1016/0040-6031(94)01884-j10.1016/0040-6031(94)01884-j ↗
57. Nagarsenker M. S. · 2016 · 52
58. 10.1016/0378-5173(89)90040-910.1016/0378-5173(89)90040-9 ↗
59. 10.1016/s0378-5173(03)00069-310.1016/s0378-5173(03)00069-3 ↗
60. 10.1016/0005-2736(93)90105-910.1016/0005-2736(93)90105-9 ↗
61. 10.1007/bf0111743410.1007/bf01117434 ↗
62. Nounou M. M. · 2005
63. Sabliov C. · 201510.1002/9781118462157 ↗
64. 10.1016/0378-5173(93)90356-k10.1016/0378-5173(93)90356-k ↗